Additional Information
The NIDA HIV Research Program invites you to a symposium featuring innovative research at the nexus of HIV and substance use disorders led by recipients of Avenir Award Program (DP2) grants (PAR-23-125).
- Joshua Barocas, M.D., University of Colorado School of Medicine
Rethinking What Information Matters and How People Get Counted to Reduce Overdose Deaths - Christina Meade, Ph.D., Wake Forest University School of Medicine
HIV and Substance Use Comorbidity: From Social to Neural Networks - Pablo Penaloza-MacMaster, Ph.D., Northwestern University
Developing IFN-Modulated Vaccines to Prevent Intravenous Infections - Alon Herschhorn, Ph.D., University of Minnesota
Delineation and Vulnerabilities of HIV-1 Escape from Neutralizing Antibodies
You can review the 2022 Avenir Symposium and the 2021 Avenir Symposium, providing insights into other groundbreaking early-stage investigators at the intersection of HIV and substance use.
HRP also funds the complementary Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research to support potentially transformative studies by investigators at all career levels.
Contact HIVNews@nida.nih.gov for more information and updates on the HIV Avenir and Avant-Garde Awards.